Candel Therapeutics share price logo

Candel Therapeutics

NASDAQ: CADL

Small Cap

$11.12

+0.44

(+4.17%)

as on

Candel Therapeutics Stock Performance

as on September 16, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $10.41
    $11.14
    downward going graph

    6.38%

    Downside

    0.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.35
    $14.00
    downward going graph

    60.88%

    Downside

    25.90%

    Upside

    downward going graph

Candel Therapeutics share price movements today

Previous Close
$10.68
Open
$10.70
Volume
1.0M
Market Cap
$806.9M
Day's Low - High
$10.41 - $11.14
52 Week Low - High
$4.35 - $14.00

Candel Therapeutics Historical Returns

1 Month Return
-8.92 %
3 Month Return
+ 24.71 %
1 Year Return
+ 120.1 %
3 Year Return
+ 747.22 %
5 Year Return
+ 28.31 %

Candel Therapeutics Stock Fundamentals & Key Indicators

Check Candel Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$806.9M

EPS (TTM)

-1.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.48

Industry PE ratio

-6.33

PEG Ratio

0.09194052328074401

EBITDA

-83.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-89.38%

Candel Therapeutics Stock Valuation

Track how Candel Therapeutics P/E has moved over time to understand its valuation trends.

Candel Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-7.85x)

December 31, 2025

Today (-7.85x)

December 31, 2025

Industry (-6.33x)

December 31, 2025

Highest (-1.12x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -7.85x

Candel Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Candel Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$806.9M28.31%-7.480.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Candel Therapeutics Stock including INR - Dollar returns

The Candel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Candel Therapeutics investment value today

Current value as on today

₹2,50,298

Returns

₹1,50,298

(+150.3%)

Returns from Candel Therapeutics Stock

₹1,29,278 (+129.28%)

Dollar Impact

₹21,020 (+21.02%)

Analyst Recommendation on Candel Therapeutics Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Candel Therapeutics. Average target price of $21

Candel Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Candel Therapeutics.

What analysts predicted

47.05%UPSIDE

Target Price

$21

Current Price

$11.12

Analyzed by

6 Analysts

Target

$21.00

Candel Therapeutics target price $21, a slight upside of 47.05% compared to current price of $11.12. According to 6 analysts rating.

Indian Investors' Interest in Candel Therapeutics Stock

Search interest for Candel Therapeutics Stock has increased by 170% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:170% versus previous 30 day period

Candel Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-7
-8
-8
-8
-8
-11
-13
-15
-16
-26
EBITDA
-7
-21
-9
-13
7
-4
-10
-27
-7
-37
Interest Expense
0
0
0
0
0
0
0
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Candel Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
-
-
-
Gross Profit
0
0
0
0
-
-
-
Operating Income
-9
-13
-25
-34
-38
-33
-48
EBITDA
-8
-13
-36
-16
-34
-52
-35
Interest Expense
-
-
-
1
2
2
2
Depreciation
0
0
-
0
0
0
0
Income Before Tax
-8
-17
-36
-18
-37
-55
-38
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-8
-17
-36
-18
-37
-55
-38
Net Profit Margin
-5185.60%
100.00%
-11575.20%
100.00%
0.00%
0.00%
0.00%

Candel Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-22
-10
-14
7
-4
-11
-29
-8
-38
Operating Cash Flow
-8
-6
-6
-5
-8
-8
-10
-10
-18
-17
Investing Cash Flow
0
0
-
0
0
0
0
0
0
0
Financing Cash Flow
-1
1
1
91
-1
17
-3
43
93
23
Change in Cash
-9
-4
-4
86
-10
8
-13
32
75
6

Candel Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-17
-36
-18
-37
-55
-38
Operating Cash Flow
-5
-9
-22
-31
-34
-27
-38
Investing Cash Flow
-35
38
-1
-1
0
0
0
Financing Cash Flow
21
0
71
19
0
94
56
Change in Cash
-18
29
47
-12
-34
67
17

Mutual Funds that own Candel Therapeutics Stock

Check out the Mutual Funds with significant holdings in Candel Therapeutics.

Funds
Holdings
Shares Held
Fidelity Select Portfolios
7.726166%
5911951
Fidelity Mt. Vernon Street Trust
3.553458%
2719055
VANGUARD INDEX FUNDS
3.146227%
2407448
Fidelity Salem Street Trust
0.643924%
492722
Fidelity Concord Street Trust
0.503398%
385193

Global Institutional Holdings in Candel Therapeutics

Funds
Holdings
Direxion
0.1%
Vanguard
4.14%
iShares
4.09%
SPDR
3.39%
Michael Rockefeller
0.2%

Insights on Candel Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CADL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CADL stock has moved up by 39.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 478.8% return, outperforming this stock by 349.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -8.86M → -38.90M (in $), with an average decrease of 339.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.77M → 1.0M (in $), with an average decrease of 43.7% per quarter

About Candel Therapeutics

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
OrganisationCandel Therapeutics
Headquarters117 Kendrick Street, Needham, MA, United States, 02494
IndustryBiotechnology
CEODr. Paul-Peter Tak FOCIS, M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Candel Therapeutics

Name

Title

Mr. Charles Schoch

Senior VP, CFO, Treasurer & Secretary

Dr. Francesca Barone M.D., Ph.D.

Chief Scientific Officer

Dr. Seshu Tyagarajan Ph.D.

Chief Technical & Development Officer

Ms. Ileen B. Winick

Chief People Officer

Ms. Susan Stewart J.D., L.L.M.

Chief Regulatory Officer

Dr. William Nichols Garrett M.D., M.S.

Chief Medical Officer

Mr. Mark Sims

Chief Commercial Officer

Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

President, CEO & Director

FAQs

What is Candel Therapeutics share price today?

Candel Therapeutics share price today is $11.12 as on at the close of the market. Candel Therapeutics share today touched a day high of $11.14 and a low of $10.41.

What is the 52 week high and 52 week low for Candel Therapeutics share?

Candel Therapeutics share touched a 52 week high of $14.00 on and a 52 week low of $4.35 on . Candel Therapeutics stock price today i.e. is closed at $11.12,which is 20.57% down from its 52 week high and 155.63% up from its 52 week low.

What is Candel Therapeutics's market capitalisation today?

Candel Therapeutics market capitalisation is $0.00T as on .

How to invest in Candel Therapeutics Stock (CADL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Candel Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Candel Therapeutics Shares that will get you 0.1349 shares as per Candel Therapeutics share price of $11.12 per share as on September 16, 2026 at 8:45 am IST.

What is the minimum amount required to buy Candel Therapeutics Stock (CADL) from India?

Indian investors can start investing in Candel Therapeutics (CADL) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Candel Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Candel Therapeutics share’s latest price of $11.12 as on September 16, 2026 at 8:45 am IST, you will get 0.8993 shares of Candel Therapeutics. Learn more about fractional shares .

What are the returns that Candel Therapeutics has given to Indian investors in the last 5 years?

Candel Therapeutics stock has given 28.31% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?